Journal of Clinical Endocrinology & Metabolism, Vol 51, 1128-1132, Copyright © 1980 by Endocrine Society

ARTICLES

Enhanced conversion of androstenedione to estrogens in obese males

HK Kley, T Deselaers, H Peerenboom and HL Kruskemper

In normal and obese young males [90--120% and > 160% of ideal body weight (IBW); IBW = 100%], plasma concentrations of testosterone, androstenedione, estrone, and estradiol were measured. Metabolic clearance and production rates of androstenedione and the conversion ratios of androstenedione to testosterone, estrone, and estradiol were determined using the constant infusion technique. In the obese subjects, IBW was inversely correlated (P < 0.001) with plasma concentrations of androstenedione (r = 0.81) and testosterone (r = 0.87), while the levels of estrone (r = 0.92) and estradiol (r = 0.95) increased with IBW (P < 0.001). Thus, when normal and obese subjects were compared as groups, plasma androstenedione decreased form 1.24 +/- 0.13 to 0.93 +/- 0.15 ng/ml (mean +/- SD) and plasma testosterone decreased from 5.89 +/- 0.82 to 3.29 +/- 0.92 ng/ml (P < 0.001), while estrone increased from 28.2 +/- 3.4 to 60.0 +/- 9.4 pg/ml, and estradiol increased from 21.7 +/- 3.5 to 43.9 +/- 5.3 pg/ml. The testosterone to androstenedione and the estradiol to estrone ratios were not different in obesity, but changes in IBW were positively correlated (P < 0.001) with differences in the estrone to androstenedione (r = 0.93) and estradiol to testosterone ratios (r = 0.93), indicating that fat tissue may aromatize androgens, whereas reduction of 17-oxo-steroid appears to be of minor importance. As the MCR of androstenedione increased with IBW (from 2156 to 2636 liters/day P < 0.05) while plasma levels decreased, the apparent production rate of androstenedione was not influenced by the degree of obesity. The conversion of androstenedione to estrone (r = 0.89) and of androstenedione to estradiol (r = 0.82) was enhanced in obese subjects (P < 0.001). We suggest that enhanced aromatization of androstenedione due to an increased adipose tissue mass may account for the high plasma estrogen levels observed in obese men.

This article has been cited by other articles:

				S. S. Kasturi, J. Tannir, and R. E. Brannigan The Metabolic Syndrome and Male Infertility J Androl, May 1, 2008; 29(3): 251 - 259. [Abstract] [Full Text] [PDF]

				M. R. Smith Obesity and Sex Steroids during Gonadotropin-Releasing Hormone Agonist Treatment for Prostate Cancer Clin. Cancer Res., January 1, 2007; 13(1): 241 - 245. [Abstract] [Full Text] [PDF]

				W. A. Bauman, A. M. Spungen, J. Wang, R. N. Pierson Jr., and E. Schwartz Relationship of fat mass and serum estradiol with lower extremity bone in persons with chronic spinal cord injury Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1098 - E1103. [Abstract] [Full Text] [PDF]

				W. de Ronde, A. Hofman, H. A P Pols, and F. H de Jong A direct approach to the estimation of the origin of oestrogens and androgens in elderly men by comparison with hormone levels in postmenopausal women Eur. J. Endocrinol., February 1, 2005; 152(2): 261 - 268. [Abstract] [Full Text] [PDF]

				G. A. Brown, M. D. Vukovich, E. R. Martini, M. L. Kohut, W. D. Franke, D. A. Jackson, and D. S. King Endocrine Responses to Chronic Androstenedione Intake in 30- to 56-Year-Old Men J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4074 - 4080. [Abstract] [Full Text]

				T. K. Murphy, E. E. Calle, C. Rodriguez, H. S. Kahn, and M. J. Thun Body Mass Index and Colon Cancer Mortality in a Large Prospective Study Am. J. Epidemiol., November 1, 2000; 152(9): 847 - 854. [Abstract] [Full Text] [PDF]

				R. Palusinski, W. Barud, T. O'Gara, K. Ullis, T. N. Ziegenfuss, R. Cohen, W. D. Brink, W. J. Roberts, D. S. King, R. L. Sharp, et al. Effects of Androstenedione in Young Men JAMA, February 9, 2000; 283(6): 741 - 743. [Full Text] [PDF]

				J. A. Langlois, M. Visser, L. S. Davidovic, S. Maggi, G. Li, and T. B. Harris Hip Fracture Risk in Older White Men Is Associated With Change in Body Weight From Age 50 Years to Old Age Arch Intern Med, May 11, 1998; 158(9): 990 - 996. [Abstract] [Full Text] [PDF]